⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SCYX News
SCYNEXIS, Inc.
SCYNEXIS Reports Full Year 2025 Financial Results and Provides Corporate Update
globenewswire.com
SCYX
SCYNEXIS Announces First Participants Dosed in a Phase 1 Single Ascending Dose and Multiple Ascending Dose Trial of Intravenous SCY-247
globenewswire.com
SCYX
CERo Therapeutics Announces Biotech Industry Veteran Eric Francois to Join its Board of Directors
globenewswire.com
SCYX
CRVO
Invasive Fungal Infections Market to Witness Upsurge in Growth at a CAGR of 11.4% (in the US) During the Forecast Period (2025-2034) | DelveInsight
prnewswire.com
GSK
SCYX
PFE
MRK
CDTX
AMPH
ASTX
SCYNEXIS Announces Presentations Highlighting the Potent Antifungal Activity of its Second-Generation Fungerp, SCY-247 Against Drug-Resistant Fungi, at the Inaugural Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI)
globenewswire.com
SCYX
SCYNEXIS Receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designations for SCY-247
globenewswire.com
SCYX
SCYNEXIS Receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designations for SCY-247
globenewswire.com
SCYX
Rifles Market Analysis and Growth Forecast 2026-2032: Key Global and Regional Trends and Opportunities
globenewswire.com
SWBI
RGR
VFC
SCYX
SCYNEXIS Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
globenewswire.com
SCYX
SCYNEXIS Completes Transfer of BREXAFEMME® New Drug Application to GSK
globenewswire.com
SCYX